liu.seSearch for publications in DiVA
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries
Univ Ottawa, Canada; Ottawa Hosp, Canada; Univ Ottawa, Canada; Kings Coll London, England; Univ Southampton, England.
Yonsei Univ, South Korea.
Kyung Hee Univ, South Korea; Kyung Hee Univ, South Korea.
Sejong Univ, South Korea; Sungkyunkwan Univ, South Korea.
Vise andre og tillknytning
2022 (engelsk)Inngår i: Molecular Psychiatry, ISSN 1359-4184, E-ISSN 1476-5578, Vol. 27, nr 10, s. 4172-4180Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Autism spectrum disorder (ASD) substantially contributes to the burden of mental disorders. Improved awareness and changes in diagnostic criteria of ASD may have influenced the diagnostic rates of ASD. However, while data on trends in diagnostic rates in some individual countries have been published, updated estimates of diagnostic rate trends and ASD-related disability at the global level are lacking. Here, we used the Global Burden of Diseases, Injuries, and Risk Factors Study data to address this gap, focusing on changes in prevalence, incidence, and disability-adjusted life years (DALYs) of ASD across the world. From 1990 to 2019, overall age-standardized estimates remained stable globally. Both prevalence and DALYs increased in countries with high socio-demographic index (SDI). However, the age-standardized incidence decreased in some low SDI countries, indicating a need to improve awareness. The male/female ratio decreased between 1990 and 2019, possibly accounted for by increasing clinical attention to ASD in females. Our results suggest that ASD detection in low SDI countries is suboptimal, and that ASD prevention/treatment in countries with high SDI should be improved, considering the increasing prevalence of the disorder. Additionally, growing attention is being paid to ASD diagnosis in females, who might have been left behind by ASD epidemiologic and clinical research previously. ASD burden estimates are underestimated as GBD does not account for mortality in ASD.

sted, utgiver, år, opplag, sider
SPRINGER NATURE , 2022. Vol. 27, nr 10, s. 4172-4180
HSV kategori
Identifikatorer
URN: urn:nbn:se:liu:diva-187504DOI: 10.1038/s41380-022-01630-7ISI: 000818605500002PubMedID: 35768640Scopus ID: 2-s2.0-85133181447OAI: oai:DiVA.org:liu-187504DiVA, id: diva2:1690140
Tilgjengelig fra: 2022-08-25 Laget: 2022-08-25 Sist oppdatert: 2023-04-05

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Søk i DiVA

Av forfatter/redaktør
Dragioti, Elena
Av organisasjonen
I samme tidsskrift
Molecular Psychiatry

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 137 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf